Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 11.14B | 11.24B | 10.85B | 10.55B | 10.19B | 10.20B |
Gross Profit | 2.60B | 2.62B | 2.42B | 2.16B | 2.15B | 2.23B |
EBITDA | 1.86B | 2.34B | 2.29B | 2.03B | 2.05B | 2.35B |
Net Income | 916.75M | 917.30M | 863.81M | 716.67M | 800.28M | 995.98M |
Balance Sheet | ||||||
Total Assets | 22.11B | 22.35B | 22.08B | 22.03B | 21.91B | 22.85B |
Cash, Cash Equivalents and Short-Term Investments | 5.01B | 5.22B | 6.79B | 6.20B | 5.65B | 6.16B |
Total Debt | 3.09B | 2.90B | 3.40B | 4.20B | 4.96B | 6.48B |
Total Liabilities | 5.59B | 5.58B | 6.09B | 6.89B | 7.37B | 9.01B |
Stockholders Equity | 16.52B | 16.78B | 16.00B | 15.15B | 14.54B | 13.84B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.70B | 1.68B | 1.48B | 1.10B | -96.96M |
Operating Cash Flow | 0.00 | 1.95B | 2.10B | 1.85B | 1.56B | 975.90M |
Investing Cash Flow | 0.00 | -242.52M | -413.54M | -283.41M | -291.61M | -706.14M |
Financing Cash Flow | 0.00 | -747.00M | -983.88M | -919.52M | -1.70B | -1.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥8.56B | 11.47 | 2.50% | 2.20% | -6.32% | ||
80 Outperform | ¥12.44B | 13.56 | 2.24% | 14.84% | 7.57% | ||
73 Outperform | ¥52.18B | 18.63 | 2.22% | 11.47% | 21.72% | ||
71 Outperform | ¥26.18B | 16.33 | 3.04% | 5.01% | -5.30% | ||
71 Outperform | ¥12.34B | 13.46 | 1.85% | 3.54% | 6.14% | ||
68 Neutral | $2.52B | 13.38 | 7.40% | 4.65% | -0.87% | 8.24% | |
66 Neutral | ¥4.90B | 5.41 | 2.43% | 0.09% | 100.67% |